Stay updated with breaking news from Diffusion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for degenerative diseases of the brain, announced an...
/PRNewswire/ -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for degenerative diseases of the brain, today announced...
/PRNewswire/ -- CervoMed Inc. (NASDAQ: CRVO), a clinical-stage company focused on developing treatments for degenerative diseases of the brain, today announced...
StockNews.com started coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Free Report) in a report published on Sunday morning. The brokerage issued a hold rating on the stock. Diffusion Pharmaceuticals Trading Up 11.7 % Diffusion Pharmaceuticals stock opened at $4.40 on Friday. The firm has a 50 day moving average price of $4.64 and a […]
/PRNewswire/ -- CervoMed Inc., a clinical stage company focused on developing treatments for degenerative diseases of the brain, today announced the...